Li H - Search Results

1

PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.

Wu C, Duan L, Li H, Liu X, Cai T, Yang Y, Yin Y, Chang W, Zhong L, Zhang L, Cheng Y, Qin H, Wen Z, Wang H, Mai S. Wu C, et al. Among authors: li h. Clin Transl Med. 2023 Jun;13(6):e1303. doi: 10.1002/ctm2.1303. Clin Transl Med. 2023. PMID: 37313656 Free PMC article.

2

Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.

Miao H, Ren Q, Li H, Zeng M, Chen D, Xu C, Chen Y, Wen Z. Miao H, et al. Among authors: li h. BMC Cancer. 2022 Mar 2;22(1):225. doi: 10.1186/s12885-022-09314-9. BMC Cancer. 2022. PMID: 35236309 Free PMC article.

3

CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling.

Chen D, Zhou H, Cai Z, Cai K, Liu J, Wang W, Miao H, Li H, Li R, Li X, Chen Y, Wang HY, Wen Z. Chen D, et al. Among authors: li h, li x, li r. J Exp Clin Cancer Res. 2022 Apr 1;41(1):120. doi: 10.1186/s13046-022-02299-0. J Exp Clin Cancer Res. 2022. PMID: 35365208 Free PMC article.

4

High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma.

Li H, Tang L, Han X, Zhong L, Gao W, Chen Y, Huang J, Wen Z. Li H, et al. Ann Diagn Pathol. 2022 Dec;61:152051. doi: 10.1016/j.anndiagpath.2022.152051. Epub 2022 Oct 13. Ann Diagn Pathol. 2022. PMID: 36272333

5

Development of a copper metabolism-related gene signature in lung adenocarcinoma.

Chang W, Li H, Zhong L, Zhu T, Chang Z, Ou W, Wang S. Chang W, et al. Among authors: li h. Front Immunol. 2022 Nov 29;13:1040668. doi: 10.3389/fimmu.2022.1040668. eCollection 2022. Front Immunol. 2022. PMID: 36524120 Free PMC article.

6

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma.

Chang W, Li H, Ou W, Wang SY. Chang W, et al. Among authors: li h. Front Immunol. 2023 Mar 24;14:1147528. doi: 10.3389/fimmu.2023.1147528. eCollection 2023. Front Immunol. 2023. PMID: 37033934 Free PMC article.

7

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.

Chang W, Li H, Cheng Y, He H, Ou W, Wang SY. Chang W, et al. Among authors: li h. Front Immunol. 2023 Apr 4;14:1171145. doi: 10.3389/fimmu.2023.1171145. eCollection 2023. Front Immunol. 2023. PMID: 37081889 Free PMC article.

8

Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.

Li H, Miao Y, Zhong L, Feng S, Xu Y, Tang L, Wu C, Zhang X, Gu L, Diao H, Wang H, Wen Z, Yang M. Li H, et al. Front Immunol. 2023 Apr 28;14:1162032. doi: 10.3389/fimmu.2023.1162032. eCollection 2023. Front Immunol. 2023. PMID: 37187751 Free PMC article.

9

TP53 Mutations in Esophageal Squamous Cell Carcinoma.

Zhong L, Li H, Chang W, Ao Y, Wen Z, Chen Y. Zhong L, et al. Among authors: li h. Front Biosci (Landmark Ed). 2023 Sep 24;28(9):219. doi: 10.31083/j.fbl2809219. Front Biosci (Landmark Ed). 2023. PMID: 37796679 Free article. Review.

10

Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.

Li H, Wu C, Chang W, Zhong L, Gao W, Zeng M, Wen Z, Mai S, Chen Y. Li H, et al. Front Biosci (Landmark Ed). 2023 Oct 19;28(10):243. doi: 10.31083/j.fbl2810243. Front Biosci (Landmark Ed). 2023. PMID: 37919070 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119,418 results

Search Page

Filters